These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24671226)

  • 1. Estrogen receptor β2 is inversely correlated with Ki-67 in hyperplastic and noninvasive neoplastic breast lesions.
    Chantzi NI; Palaiologou M; Stylianidou A; Goutas N; Vassilaros S; Kourea HP; Dhimolea E; Mitsiou DJ; Tiniakos DG; Alexis MN
    J Cancer Res Clin Oncol; 2014 Jun; 140(6):1057-66. PubMed ID: 24671226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
    Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
    Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer.
    Huang B; Omoto Y; Iwase H; Yamashita H; Toyama T; Coombes RC; Filipovic A; Warner M; Gustafsson JÅ
    Proc Natl Acad Sci U S A; 2014 Feb; 111(5):1933-8. PubMed ID: 24449868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor beta 2 is associated with poor prognosis in estrogen receptor alpha-negative breast carcinoma.
    Chantzi NI; Tiniakos DG; Palaiologou M; Goutas N; Filippidis T; Vassilaros SD; Dhimolea E; Mitsiou DJ; Alexis MN
    J Cancer Res Clin Oncol; 2013 Sep; 139(9):1489-98. PubMed ID: 23817696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of ER, Ki-67 and cylinD1 in the pre-cancerous breast of Chinese patients.
    Zhou CJ; Zhang QH; Zhang TG; Sun SZ; Li H; Wang Y; Liu ZY
    Pathol Oncol Res; 2009 Jun; 15(2):153-8. PubMed ID: 18941930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression pattern and methylation of estrogen receptor α in breast intraductal proliferative lesions.
    Mao X; Qiao Z; Fan C; Guo A; Yu X; Jin F
    Oncol Rep; 2016 Oct; 36(4):1868-74. PubMed ID: 27498697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
    Yang M; Xu SP; Ao QL
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of 14-3-3 sigma and related proteins in hyperplastic and neoplastic breast lesions, with particular reference to early carcinogenesis.
    Simooka H; Oyama T; Sano T; Horiguchi J; Nakajima T
    Pathol Int; 2004 Aug; 54(8):595-602. PubMed ID: 15260850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma.
    Abdel-Fatah TM; Powe DG; Hodi Z; Lee AH; Reis-Filho JS; Ellis IO
    Am J Surg Pathol; 2007 Mar; 31(3):417-26. PubMed ID: 17325484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acid receptor and retinoid X receptor in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Sasano H
    Jpn J Cancer Res; 2000 Nov; 91(11):1169-76. PubMed ID: 11092983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ.
    Martinez AP; Cohen C; Hanley KZ; Li XB
    Arch Pathol Lab Med; 2016 Jul; 140(7):686-9. PubMed ID: 27116088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
    Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 nuclear accumulation and ERalpha expression in ductal hyperplasia of breast in a cohort of 215 Chinese women.
    Mao XY; Fan CF; Zheng HC; Wei J; Yao F; Jin F
    J Exp Clin Cancer Res; 2010 Aug; 29(1):112. PubMed ID: 20712900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a.
    Bertagnolo V; Grassilli S; Volinia S; Al-Qassab Y; Brugnoli F; Vezzali F; Lambertini E; Palomba M; Piubello Q; Orvieto E; Natali C; Piva R; Croce CM; Capitani S
    Mol Carcinog; 2019 May; 58(5):708-721. PubMed ID: 30582225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociated overexpression of cathepsin D and estrogen receptor alpha in preinvasive mammary tumors.
    Roger P; Daures JP; Maudelonde T; Pignodel C; Gleizes M; Chapelle J; Marty-Double C; Baldet P; Mares P; Laffargue F; Rochefort H
    Hum Pathol; 2000 May; 31(5):593-600. PubMed ID: 10836299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptors β1 and β2 are associated with distinct responses of estrogen receptor α-positive breast carcinoma to adjuvant endocrine therapy.
    Dhimolea E; Tiniakos DG; Chantzi ΝΙ; Goutas N; Vassilaros SD; Mitsiou DJ; Alexis ΜN
    Cancer Lett; 2015 Mar; 358(1):37-42. PubMed ID: 25524554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis.
    Bos R; Zhong H; Hanrahan CF; Mommers EC; Semenza GL; Pinedo HM; Abeloff MD; Simons JW; van Diest PJ; van der Wall E
    J Natl Cancer Inst; 2001 Feb; 93(4):309-14. PubMed ID: 11181778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histological grading in ductal carcinoma in situ of the breast].
    Xu W; Zhu X; Zhang T; Tu X; Shi D
    Zhonghua Bing Li Xue Za Zhi; 1999 Oct; 28(5):331-3. PubMed ID: 11869542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased estrogen receptor betacx expression during mammary carcinogenesis.
    Esslimani-Sahla M; Kramar A; Simony-Lafontaine J; Warner M; Gustafsson JA; Rochefort H
    Clin Cancer Res; 2005 May; 11(9):3170-4. PubMed ID: 15867209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.